Adhera Therapeutics, Inc. Selling, General and Administrative Expense
Adhera Therapeutics, Inc. reported Selling, General and Administrative Expense of $5.25 million for the 12-month period ending 2012-12-31, per its 10-K filed 2014-07-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2014-07-22
- Adhera Therapeutics, Inc. selling, general and administrative expense for the quarter ending 2012-12-31 was $1.94M, a 4.18% increase year-over-year.
- Adhera Therapeutics, Inc. selling, general and administrative expense for the quarter ending 2012-09-30 was $598.00K, a 67.71% decline year-over-year.
- Adhera Therapeutics, Inc. selling, general and administrative expense for the quarter ending 2012-06-30 was $992.00K, a 63.90% decline year-over-year.
- Adhera Therapeutics, Inc. selling, general and administrative expense for the quarter ending 2012-03-31 was $1.72M, a 9.83% decline year-over-year.
- Adhera Therapeutics, Inc. selling, general and administrative expense for fiscal 2012 was $5.25M, a 37.27% decline from fiscal 2011.
- Adhera Therapeutics, Inc. selling, general and administrative expense for fiscal 2011 was $8.37M, a 19.21% decline from fiscal 2010.
- Adhera Therapeutics, Inc. selling, general and administrative expense for fiscal 2010 was $10.36M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2012-12-31 | $1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-22 | $2.54M derived: sum of 2 quarters · filed 2014-07-22 | $3.53M derived: sum of 3 quarters · filed 2014-07-22 | $5.25M 10-K · filed 2014-07-22 |
| 2012-09-30 | $598.00K 10-Q · filed 2012-12-05 | $1.59M derived: sum of 2 quarters · filed 2012-12-05 | $3.31M 10-Q · filed 2012-12-05 | $5.17M derived: sum of 4 quarters · filed 2014-07-22 |
| 2012-06-30 | $992.00K 10-Q · filed 2012-12-05 | $2.71M 10-Q · filed 2012-12-05 | $4.57M derived: sum of 3 quarters · filed 2014-07-22 | $6.43M derived: sum of 4 quarters · filed 2014-07-22 |
| 2012-03-31 | $1.72M 10-Q · filed 2012-12-05 | $3.58M derived: sum of 2 quarters · filed 2014-07-22 | $5.43M derived: sum of 3 quarters · filed 2014-07-22 | $8.18M derived: sum of 4 quarters · filed 2014-07-22 |
| 2011-12-31 | $1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-22 | $3.72M derived: sum of 2 quarters · filed 2014-07-22 | $6.47M derived: sum of 3 quarters · filed 2014-07-22 | $8.37M 10-K · filed 2014-07-22 |
| 2011-09-30 | $1.85M 10-Q · filed 2012-12-05 | $4.60M derived: sum of 2 quarters · filed 2012-12-05 | $6.50M 10-Q · filed 2012-12-05 | $8.10M derived: sum of 4 quarters · filed 2012-12-05 |
| 2011-06-30 | $2.75M 10-Q · filed 2012-12-05 | $4.65M 10-Q · filed 2012-12-05 | $6.25M derived: sum of 3 quarters · filed 2012-12-05 | $10.20M derived: sum of 4 quarters · filed 2012-12-05 |
| 2011-03-31 | $1.90M 10-Q · filed 2012-12-05 | $3.50M derived: sum of 2 quarters · filed 2012-12-05 | $7.46M derived: sum of 3 quarters · filed 2012-12-05 | $9.70M derived: sum of 4 quarters · filed 2012-12-05 |
| 2010-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2012-10-10 | $5.55M derived: sum of 2 quarters · filed 2012-10-10 | $7.80M derived: sum of 3 quarters · filed 2012-10-10 | $10.36M 10-K · filed 2012-10-10 |
| 2010-09-30 | $3.96M 10-Q · filed 2011-11-10 | $6.20M derived: sum of 2 quarters · filed 2011-11-10 | $8.76M 10-Q · filed 2011-11-10 | |
| 2010-06-30 | $2.25M 10-Q · filed 2011-08-11 | $4.81M 10-Q · filed 2011-08-11 |